Pyrovalerone
| O-2371 | |
|---|---|
| Salts [] | |
|---|---|
| Pyrovalerone hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 245.36 g/mol [1] |
| Predicted LogP | 3.8 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C16H23NO |
| IUPAC name | 1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one |
| SMILES | CCCC(C(=O)C1=CC=C(C=C1)C)N2CCCC2 |
| InChI | InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3 |
| InChIKey | SWUVZKWCOBGPTH-UHFFFAOYSA-N |
| CAS number | 3563-49-3 |
| UNII | VOU69C02JP |
| PubChem CID | 14373 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | By mouth |
Pyrovalerone (also known as Pirovalerona, Pyrovaleronum, 4'-Methyl-2-(1-pyrrolidinyl)valerophenone, J8.659b, 1-Pentanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-, 1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one, 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one, Valerophenone, 4'-methyl-2-(1-pyrrolidinyl)-, Epitope ID:2279524 or Daa56349) is a stimulant substance of the cathinone and pyrrolidinophenone class.
Chemistry
Salts []
Pyrovalerone is typically found in the form of its hydrochloride salt.
Stereochemistry []
Pyrovalerone is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Pyrovalerone matches Lipinski's rule of five.Reagents
There are currently 6 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | no color change | |
| Liebermann | yellowish | |
| Froehde | no color change | |
| Gallic | no color change |
Pharmacology
MeSH Classification
- central nervous system stimulants (M0001063)
Subjective effects []
Legal status []
- Australia: Pyrovalerone is a Schedule 4.
- Brazil: Pyrovalerone is a B1.[3]
- Canada: Pyrovalerone is a Schedule IV.
- United States: Pyrovalerone is a Schedule V under the "Controlled Substances Act".
- United Kingdom: Pyrovalerone is a Class C under the "Misuse of Drugs Act 1971".
- Germany: Pyrovalerone is a Anlage II under the "Betäubungsmittelgesetz (BtMG)".
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 14373, Pyrovalerone. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/14373
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Pyrovalerone. UNII: VOU69C02JP. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/VOU69C02JP
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:45:12 |
| drugspro | ok | 2026-11-20 09:45:08 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 09:45:08 |
| gsrs | ok | 2026-11-20 09:45:09 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0256994) | 2026-11-20 09:45:08 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 09:45:12 |
| pubchem | ok | 2026-11-20 09:45:06 |
| missing (no r/tripreports posts mention it) | 2026-11-20 09:45:08 | |
| sider | missing (not in SIDER) | 2026-11-20 09:45:08 |
| structure | ok | 2026-11-20 09:45:08 |
| wikipedia | ok | 2026-11-20 09:45:08 |